Improving the science of abuse assessment before a drug is marketed is a unified goal for the FDA and pharmaceutical industry. It is the hope that public health will be protected through placing appropriate controls, such as accurate labeling information and marketing practices, to reduce the likelihood that a drug will be abused after FDA approval.

The Fundamentals of Human Abuse Potential (HAP) Studies: A 7-Point Checklist

Explore related content and topics